Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies

Kükenshöner, Tim; Schmit, Nadine Eliane; Bouda, Emilie; Sha, Fern; Pojer, Florence; Koide, Akiko; Seeliger, Markus; Koide, Shohei; Hantschel, Oliver

doi:10.1016/j.jmb.2017.03.023

Title: Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies

Full Record
Other Related Research

Authors:: Kükenshöner, Tim; Schmit, Nadine Eliane; Bouda, Emilie; Sha, Fern; Pojer, Florence; Koide, Akiko; Seeliger, Markus; Koide, Shohei; Hantschel, Oliver

Publication Date:: 2017-05-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1379995

Grant/Contract Number:: AC02-06CH11357

Resource Type:: Published Article

Journal Name:: Journal of Molecular Biology

Additional Journal Information:: Journal Name: Journal of Molecular Biology Journal Volume: 429 Journal Issue: 9; Journal ID: ISSN 0022-2836

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Kükenshöner, Tim, Schmit, Nadine Eliane, Bouda, Emilie, Sha, Fern, Pojer, Florence, Koide, Akiko, Seeliger, Markus, Koide, Shohei, and Hantschel, Oliver. Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.  United Kingdom: N. p., 2017. 
Web.  doi:10.1016/j.jmb.2017.03.023.

Copy to clipboard


                    Kükenshöner, Tim, Schmit, Nadine Eliane, Bouda, Emilie, Sha, Fern, Pojer, Florence, Koide, Akiko, Seeliger, Markus, Koide, Shohei, & Hantschel, Oliver. Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.  United Kingdom.  https://doi.org/10.1016/j.jmb.2017.03.023

Copy to clipboard


                    Kükenshöner, Tim, Schmit, Nadine Eliane, Bouda, Emilie, Sha, Fern, Pojer, Florence, Koide, Akiko, Seeliger, Markus, Koide, Shohei, and Hantschel, Oliver. Mon .  
"Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies".  United Kingdom.  https://doi.org/10.1016/j.jmb.2017.03.023.

Copy to clipboard


                    
@article{osti_1379995,

  title        = {Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies},

  author       = {Kükenshöner, Tim and Schmit, Nadine Eliane and Bouda, Emilie and Sha, Fern and Pojer, Florence and Koide, Akiko and Seeliger, Markus and Koide, Shohei and Hantschel, Oliver},

  abstractNote = {},

  doi          = {10.1016/j.jmb.2017.03.023},

  journal      = {Journal of Molecular Biology},

  number       = 9,

  volume       = 429,

  place        = {United Kingdom},

  year         = {2017},

  month        = {5}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
https://doi.org/10.1016/j.jmb.2017.03.023

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 6 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies

Journal Article Kükenshöner, Tim ; Schmit, Nadine Eliane ; Bouda, Emilie ; ... - Journal of Molecular Biology

The binding of Src-homology 2 (SH2) domains to phosphotyrosine (pY) sites is critical for the autoinhibition and substrate recognition of the eight Src family kinases (SFKs). The high sequence conservation of the 120 human SH2 domains poses a significant challenge to selectively perturb the interactions of even the SFK SH2 family against the rest of the SH2 domains. We have developed synthetic binding proteins, termed monobodies, for six of the SFK SH2 domains with nanomolar affinity. Most of these monobodies competed with pY ligand binding and showed strong selectivity for either the SrcA (Yes, Src, Fyn, Fgr) or SrcB subgroupmore »« less
https://doi.org/10.1016/j.jmb.2017.03.023
Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton`s tyrosine kinase and direct female carrier evaluation in a family with x-linked agammaglobulinemia

Journal Article Schuster, V ; Seidenspinner, S ; Wolfgang Kreth, H - American Journal of Medical Genetics

X-linked agammaglobulinemia (XLA) is an inherited immunodeficiency disease with a block in differentiation from pre-B to B cells resulting in a selective defect in the humoral immune response. Affected males have very low concentrations of serum immunoglobulins leading predominantly to recurrent bacterial infections beginning at age 6 to 18 months. The gene responsible for XLA was identified recently to encode a cytoplasmatic tyrosine kinase (Bruton`s tyrosine kinase, BTK). We have analyzed the BTK gene in a large family in which two brothers presented with the severe phenotype of XLA. Genomic DNA of affected boys and from healthy relatives was amplifiedmore »« less
https://doi.org/10.1002/(SICI)1096-8628(19960503)63:1<318::AID-AJMG53>3.0.CO;2-N
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface

Journal Article Wojcik, John ; Lamontanara, Allan Joaquim ; Grabe, Grzegorz ; ... - Journal of Biological Chemistry

Bcr-Abl is a constitutively active kinase that causes chronic myelogenous leukemia. We have shown that a tandem fusion of two designed binding proteins, termed monobodies, directed to the interaction interface between the Src homology 2 (SH2) and kinase domains and to the phosphotyrosine-binding site of the SH2 domain, respectively, inhibits the Bcr-Abl kinase activity. Because the latter monobody inhibits processive phosphorylation by Bcr-Abl and the SH2-kinase interface is occluded in the active kinase, it remained undetermined whether targeting the SH2-kinase interface alone was sufficient for Bcr-Abl inhibition. To address this question, we generated new, higher affinity monobodies with single nanomolarmore »« less
Cited by 11
https://doi.org/10.1074/jbc.M115.707901

Full Text Available
Interaction with the Src Homology (SH3-SH2) Region of the Src-family Kinase Hck Structures the HIV-1 Nef Dimer for Kinase Activation and Effector Recruitment

Journal Article Alvarado, John Jeff ; Tarafdar, Sreya ; Yeh, Joanne I. ; ... - J. Biol. Chem.
https://doi.org/10.1074/jbc.M114.600031
Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase

Journal Article Kall, Stefanie L. ; Whitlatch, Kindra ; Smithgall, Thomas E. ; ... - Scientific Reports

Choline kinase alpha is a 457-residue protein that catalyzes the reaction between ATP and choline to yield ADP and phosphocholine. This metabolic action has been well studied because of choline kinase’s link to cancer malignancy and poor patient prognosis. As the myriad of x-ray crystal structures available for this enzyme show, chemotherapeutic drug design has centered on stopping the catalytic activity of choline kinase and reducing the downstream metabolites it produces. Furthermore, these crystal structures only reveal the catalytic domain of the protein, residues 80–457. However, recent studies provide evidence for a non-catalytic protein-binding role for choline kinase alpha. Here,more »« less
https://doi.org/10.1038/s41598-019-53447-0

Full Text Available

Similar Records